Tarbox Family Office’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-30
Closed -$6K 785
2022
Q1
$6K Hold
30
﹤0.01% 495
2021
Q4
$8K Hold
30
﹤0.01% 498
2021
Q3
$9K Hold
30
﹤0.01% 515
2021
Q2
$6K Hold
30
﹤0.01% 603
2021
Q1
$6K Hold
30
﹤0.01% 527
2020
Q4
$6K Hold
30
﹤0.01% 494
2020
Q3
$4K Hold
30
﹤0.01% 552
2020
Q2
$4K Buy
30
+24
+400% +$2.82K ﹤0.01% 549
2020
Q1
$1K Buy
+6
New +$579 ﹤0.01% 965

Other funds holding RGEN

Tarbox Family Office's RGEN Position: Q2 2022 in Review

Tarbox Family Office sold out of Repligen (RGEN) in Q2 2022, closing a stake of 30 shares — an estimated $6K sold.

Tarbox Family Office first reported a position in RGEN in Q1 2020 and held it in 9 quarters. The position peaked at $9K in Q3 2021. 405 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Tarbox Family Office reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 30 Repligen shares in Q2 2022, an estimated $6K.
  • Tarbox Family Office first reported a position in Repligen in Q1 2020 and held it in 9 quarters.
  • Tarbox Family Office's Repligen position peaked at $9K in Q3 2021.
  • 405 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.